Target Name: BMPR1A
NCBI ID: G657
Review Report on BMPR1A Target / Biomarker Content of Review Report on BMPR1A Target / Biomarker
BMPR1A
Other Name(s): BMP type-1A receptor | serine/threonine-protein kinase receptor R5 | SKR5 | BMPR-1A | Activin receptor-like kinase 3 | ALK3 | bone morphogenetic protein receptor, type IA | bone morphogenetic protein receptor type 1A | ACVRLK3 | Serine/threonine-protein kinase receptor R5 | activin A receptor, type II-like kinase 3 | 10q23del | ALK-3 | Bone morphogenetic protein receptor type 1A | activin receptor-like kinase 3 | Bone morphogenetic protein receptor type-1A | CD292 | BMR1A_HUMAN

BMPR1A: A Role in Bone, Cartilage and Connective Tissue Regulation

BMPR1A (BMP type-1A receptor) is a protein that is expressed in various tissues throughout the body, including bone, cartilage, and connective tissue. It is a member of the BMP (bone Morphogenetic Protein) family, which includes several similar receptors, including BMPR2, BMPR3, and BMPR4. BMPR1A is known for its role in the regulation of bone growth and development, and is a potential drug target in the treatment of various diseases.

The BMPR1A receptor is a G protein-coupled receptor, which means that it interacts with intracellular signaling molecules called G proteins. These molecules include IP3 (inositol trisphosphate), which is a key signaling molecule in many cellular processes, including muscle contractions and blood pressure regulation. When IP3 binds to the BMPR1A receptor, it triggers a series of downstream signaling pathways that regulate bone growth and development.

One of the key functions of BMPR1A is its role in the regulation of bone growth and development. During fetal development, the BMPR1A receptor is essential for the proper formation and growth of bones. In adulthood, it plays a critical role in the regulation of bone density and bone turnover, which are important for maintaining skeletal health and preventing osteoporosis.

BMPR1A is also involved in the regulation of inflammation and pain. Studies have shown that it is involved in the development of inflammatory diseases, including rheumatoid arthritis and osteoarthritis. It is also involved in the regulation of pain perception and may play a role in the development of chronic pain.

Another potential function of BMPR1A is its role in the regulation of cell survival and proliferation. It is known to play a role in the regulation of cell proliferation and has been shown to promote the growth and survival of various cell types, including cancer cells. This may have important implications for the development of cancer.

BMPR1A is also involved in the regulation of cardiovascular function. Studies have shown that it is involved in the regulation of heart rate and blood pressure, and may play a role in the development of cardiovascular disease.

In conclusion, BMPR1A is a protein that plays a critical role in the regulation of bone growth and development, inflammation, pain, and cardiovascular function. It is a potential drug target and may be a useful target for the treatment of various diseases. Further research is needed to fully understand the role of BMPR1A in the regulation of bone and cardiovascular health, as well as its potential as a drug target.

Protein Name: Bone Morphogenetic Protein Receptor Type 1A

Functions: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP2, BMP4, GDF5 and GDF6. Positively regulates chondrocyte differentiation through GDF5 interaction. Mediates induction of adipogenesis by GDF6

The "BMPR1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BMPR1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP | BRI3P1 | BRI3P2 | BRICD5